Outcome of Board Meeting

Revenue Growth 20pctPat NegativeExceptional ItemResults RestatedResults View source PDF

ZYDUSWELL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.9%1-day move

₹502.30

prior close

₹494.15

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.6+1.0+0.3+0.8+1.9+1.5-1.3-2.8-2.9-4.3+1.1+0.3+19.8—

Up moveDown movePending

AI summary

Zydus Wellness reported strong revenue growth with consolidated total income of ₹39,674 million (up 46% YoY) and standalone total income of ₹5,940 million (up 62% YoY). However, consolidated PAT declined significantly to ₹1,972 million from ₹3,469 million in FY25, impacted by exceptional items of ₹408 million (including acquisition costs for Comfort Click Ltd and NIPL liquidation expenses) and higher finance costs of ₹981 million (vs ₹120 million). Standalone PAT grew 27% to ₹376 million. The board recommended a final dividend of ₹1.20 per share (60% payout). Key acquisitions completed during the year include Naturell (India) Private Limited (Dec 2024) and Comfort Click Limited (Aug 2025). Auditors issued unmodified (clean) opinion on both standalone and consolidated financials.

Likely market impact

Revenue growth is impressive, but the 43% decline in consolidated PAT signals cost pressures from recent acquisitions and higher debt costs. The clean audit opinion is positive. Shareholders can expect dividend income pending AGM approval, but should monitor integration costs from acquired businesses.